Claritev Corporation Class A
As of Oct 22, 2026, Claritev is in Stage 3, the topping phase, now in week 4 (since Oct 1, 2026). It closed at $23.50, 67.1% below its 52-week high and below its 200-day average, which is falling.
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is CTEV early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CTEV among Health Information Services30th of 41 by relative strength
All 41 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | AMWL | Stage 2 · wk 25 | 97 | +7.4% |
| 2 | HNGE | Stage 2 · wk 20 | 96 | +19.1% |
| 3 | BTSG | Stage 3 · wk 8 | 94 | +9.1% |
| 4 | NRC | Stage 3 · wk 4 | 93 | −0.1% |
| 5 | SOPH | Stage 2 · wk 24 | 91 | −12.7% |
| 6 | HTFL | Stage 2 · wk 10 | 87 | +17.0% |
| 7 | HSTM | Stage 2 · wk 17 | 77 | +20.3% |
| 8 | OMCL | Stage 4 · wk 10 | 70 | +12.5% |
| …30 | CTEV | Stage 3 · wk 4 | 17 | −6.2% |
Claritev: quick answers
What stage is Claritev in?
As of Oct 22, 2026, Claritev (CTEV) is in Stage 3, the topping phase. It entered Stage 3 on Oct 1, 2026 and is in week 4. What the four stages mean
Is Claritev in an uptrend?
Its uptrend has stalled. Claritev is in Stage 3, the topping phase that follows an advance. It trades 9.3% below its 200-day average, which is falling.
How far is Claritev from its 52-week high?
Claritev closed at $23.50 on Oct 22, 2026, 67.1% below its 52-week high of $71.36. Its 52-week low is $13.47.
How has Claritev performed over the past year?
As of Oct 22, 2026, Claritev is down 64.4% over the past year and down 30.7% so far in 2026.
Which sector and industry is Claritev in?
Claritev is in the Health Information Services industry, part of the Health Care sector.
About this companyHealth Care· Health Information Services
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.